The guidelines recommend managing patients with low-risk disease by performing a digital rectal examination every 12 months. They do not recommend the use of multiparametric MRI as an initial screening tool. The guidelines say that active surveillance should be offered to patients with life expectancy > 10 years, and serum PSA assessment should be conducted every 6 months.
Learn more about the prostate cancer clinical screening guidelines.
Lead image: Kateryna Kon | Dreamstime.com
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Bradley Schwartz. Fast Five Quiz: Prostate Cancer Practice Essentials - Medscape - Apr 19, 2023.